When MS cases were classified according to the severity of meningeal inflammation, pMLKL and MLKL levels were both significantly increased in cases with more abundant meningeal inflammation when compared to those with low levels of meningeal inflammation (6.5- and 8.0-fold, respectively) (Fig. 3d). This evidence concerns the gene MLKL and myeloid sarcoma.